NPPB and Myocardial fibrosis: In a prospective cohort with three years of follow-up, Dumitru et al. reported that anti-Scl-70-positive patients had an approximately threefold increased risk of developing LGE-detected myocardial fibrosis, arrhythmias, and elevated NT-proBNP levels compared to those without the antibody.